Aquestive Therapeutics reported a gross margin of 70.93% and a net margin of -165.45% for the quarter ended Jun 2026. These financial ratios cover 37 quarters of results from Jun 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||
| Gross Margin | 66.88% | 69.62% | 65.66% | 60.48% | 59.65% | 50.34% | 57.45% | 50.03% | 63.10% | 58.49% | 63.59% | 77.48% | 67.24% | 61.91% | 58.12% | 54.40% | 64.82% | 55.16% | 75.99% | 70.93% | |||||||||||||||||
| EBT Margin | -109.54% | -261.28% | -107.74% | -122.89% | -109.36% | -115.63% | 72.46% | -41.60% | -16.73% | -60.65% | -106.43% | -13.66% | -84.99% | -143.84% | -262.96% | -135.44% | -120.61% | -244.79% | -55.77% | -165.45% | |||||||||||||||||
| EBIT Margin | -59.97% | -105.33% | -79.36% | -96.21% | -77.23% | -100.29% | -41.36% | -31.79% | -18.28% | -29.62% | -74.31% | 0.27% | -61.22% | -114.43% | -222.08% | -113.65% | -89.63% | -221.58% | -29.10% | -59.51% | |||||||||||||||||
| EBITDA Margin | -59.97% | -105.33% | -79.36% | -96.21% | -77.23% | -100.29% | -41.36% | -31.79% | -18.28% | -29.62% | -74.31% | 0.27% | -61.22% | -114.43% | -222.08% | -113.65% | -89.63% | -221.58% | -29.10% | -59.51% | |||||||||||||||||
| Operating Margin | -59.97% | -105.33% | -79.36% | -96.21% | -77.23% | -100.29% | -41.36% | -31.79% | -18.28% | -29.62% | -74.31% | 0.27% | -61.22% | -114.43% | -222.08% | -113.65% | -89.63% | -221.58% | -29.10% | -59.51% | |||||||||||||||||
| Net Margin | -109.54% | -261.28% | -107.74% | -122.89% | -109.36% | -115.63% | 72.46% | -43.74% | -15.65% | -61.42% | -106.43% | -13.66% | -84.99% | -143.72% | -262.96% | -135.44% | -120.61% | -244.79% | -55.77% | -165.45% | |||||||||||||||||
| FCF Margin | -68.85% | -77.58% | -118.88% | -54.57% | 22.61% | 78.54% | 79.16% | -65.95% | -19.21% | -37.54% | -86.39% | -35.03% | -88.32% | -54.81% | -269.90% | -80.19% | -100.60% | -65.72% | -102.85% | -69.85% | |||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 2.85M | 3.45M | 4.33M | 4.82M | 5.87M | 6.25M | 6.38M | 6.47M | 6.51M | 6.92M | 7.25M | 7.35M | 6.99M | 6.53M | 6.62M | 7.66M | 8.00M | 7.03M | 7.12M | 7.72M | |||||||||||||||||
| Assets AverageAssets Avg. | 66.08M | 63.64M | 59.26M | 56.42M | 54.08M | 54.46M | 59.18M | 59.14M | 58.22M | 58.43M | 93.47M | 123.56M | 113.78M | 105.69M | 101.83M | 97.97M | 128.63M | 161.99M | 150.78M | 136.61M | |||||||||||||||||
| Invested CapitalInvested Cap. | -19.95M | -28.56M | -38.90M | -42.79M | -54.92M | -66.41M | -66.84M | -67.49M | -63.77M | -78.96M | 8.72M | 9.54M | -0.40M | -27.63M | -27.16M | -37.57M | 32.16M | 3.85M | 24.61M | -1.55M | |||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.71 | 0.80 | 0.88 | 0.88 | 0.89 | 0.88 | 0.79 | 0.79 | 0.83 | 0.87 | 0.55 | 0.47 | 0.52 | 0.54 | 0.53 | 0.45 | 0.34 | 0.27 | 0.33 | 0.40 | |||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -2.86 | -6.69 | -6.02 | -7.81 | -5.37 | -6.49 | -3.21 | -3.07 | -1.89 | -1.72 | -3.22 | 0.02 | -2.98 | -4.89 | -6.96 | -4.09 | -4.13 | -10.38 | -1.45 | -2.93 | |||||||||||||||||
| Debt Ratio | 0.62 | 0.86 | 0.96 | 0.95 | 1.02 | 0.91 | 0.69 | 0.69 | 0.66 | 0.48 | 0.35 | 0.38 | 0.41 | 0.32 | 0.33 | 0.37 | 0.22 | 0.23 | 0.42 | 0.42 | |||||||||||||||||
| Times Interest Earned | -2.86 | -6.69 | -6.02 | -7.81 | -5.37 | -6.49 | -3.21 | -3.07 | -1.89 | -1.72 | -3.22 | 0.02 | -2.98 | -4.89 | -6.96 | -4.09 | -4.13 | -10.38 | -1.45 | -2.93 | |||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -12.01 | -5.54 | -8.22 | -2.09 | -5.03 | -4.00 | 7.90 | -17.55 | -50.18 | -17.07 | -24.45 | -86.25 | -39.45 | -19.08 | -12.56 | -24.27 | -44.03 | -24.75 | -64.02 | -22.84 | |||||||||||||||||
| Price to SalesP/S | 13.15 | 14.48 | 8.85 | 2.57 | 5.50 | 4.63 | 5.73 | 7.68 | 7.85 | 10.48 | 26.02 | 11.78 | 33.53 | 27.42 | 33.03 | 32.88 | 53.10 | 60.58 | 35.70 | 37.78 | |||||||||||||||||
| Price to BookP/B | -2.90 | -1.95 | -1.17 | -0.35 | -0.58 | -0.42 | -0.58 | -0.95 | -0.99 | -1.30 | -8.64 | -6.67 | -10.00 | -5.41 | -4.73 | -4.53 | -165.51 | -23.42 | -15.15 | -9.23 | |||||||||||||||||
| Enterprise Value | 143.60M | 132.36M | 93.89M | 16.43M | 44.36M | 22.19M | 36.87M | 79.23M | 77.20M | 114.56M | 218.40M | 146.89M | 376.17M | 253.89M | 219.36M | 268.32M | 551.01M | 667.24M | 405.05M | 423.64M | |||||||||||||||||
| EV to EBIT | -18.02 | -11.34 | -9.64 | -1.29 | -5.01 | -2.07 | -8.01 | -18.82 | -32.48 | -29.29 | -24.38 | 0.00M | -45.38 | -18.70 | -11.33 | -23.60 | -48.00 | -23.14 | -96.35 | -51.52 | |||||||||||||||||
| EV to EBITDA | -18.02 | -11.34 | -9.64 | -1.29 | -5.01 | -2.07 | -8.01 | -18.82 | -32.48 | -29.29 | -24.38 | 0.00M | -45.38 | -18.70 | -11.33 | -23.60 | -48.00 | -23.14 | -96.35 | -51.52 | |||||||||||||||||
| Market Capitalization | 174.76M | 160.38M | 108.63M | 34.13M | 63.01M | 49.46M | 63.75M | 101.67M | 102.11M | 138.44M | 313.60M | 236.76M | 454.07M | 325.43M | 288.02M | 328.86M | 680.07M | 788.41M | 515.78M | 522.13M | |||||||||||||||||
| Price to FCFP/FCF | -19.10 | -18.66 | -7.45 | -4.71 | 24.31 | 5.90 | 7.23 | -11.64 | -40.88 | -27.92 | -30.12 | -33.63 | -37.97 | -50.04 | -12.24 | -41.00 | -52.78 | -92.17 | -34.71 | -54.09 | |||||||||||||||||
| EV to FCF | -15.70 | -15.40 | -6.44 | -2.27 | 17.11 | 2.64 | 4.18 | -9.07 | -30.90 | -23.11 | -20.97 | -20.86 | -31.45 | -39.04 | -9.32 | -33.45 | -42.77 | -78.00 | -27.26 | -43.89 | |||||||||||||||||
| EV to CFO | -15.84 | -16.42 | -6.48 | -2.50 | 15.79 | 2.64 | 4.18 | -10.02 | -32.89 | -23.18 | -21.03 | -20.97 | -31.66 | -39.13 | -9.37 | -33.90 | -43.56 | -78.79 | -27.36 | -44.87 | |||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -59.97% | -105.33% | -79.36% | -96.21% | -77.23% | -100.29% | -41.36% | -31.79% | -18.28% | -29.62% | -74.31% | 0.27% | -61.22% | -114.43% | -222.08% | -113.65% | -89.63% | -221.58% | -29.10% | -59.51% | |||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -94.18% | -83.20% | -102.32% | -157.32% | -245.59% | -281.76% | -196.51% | -138.53% | -64.11% | -37.64% | -25.80% | -13.85% | -21.40% | -35.44% | -49.30% | -70.31% | -54.14% | -62.12% | -46.96% | -43.90% | |||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | 42.79% | 33.78% | 21.84% | 55.87% | -166.06% | -462.60% | 219.53% | 150.29% | |||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -93.76% | -110.84% | -116.58% | -129.43% | -131.30% | -99.91% | -55.97% | -38.24% | -20.80% | -13.47% | -30.78% | -20.81% | -30.93% | -41.76% | -53.26% | -66.39% | -53.63% | -51.72% | -45.70% | -57.26% |